While there is currently no reliable biomarker for the screening or diagnosis of mitochondrial diseases (MDs), GDF15 may be a useful novel biomarker for the specific screening of MDs because its measurement involves a less-invasive approach than muscle biopsy. Here, GDF15 is linked to myelodysplastic syndrome.